Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Masking up matters: High-quality studies confirm face masks significantly curb COVID-19 spread

This 'Special Communication' article in JAMA Network Open compiles high-quality studies to underline the effectiveness of face masks in curbing community-level transmission of SARS-CoV-2. The article emphasizes that surgical masks are more effective than cloth masks, and that mask-wearing is a vital public health tool, both in conjunction with and independent of other measures like vaccination and social distancing.

1 Nov 2023

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Age-stratified hospitalization and mortality risks from incident SARS-CoV-2 infections.

1 Nov 2023

Influence of employment during COVID-19 on cognitive and motor functions among elders

The effects of employment on geriatric health during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak.

1 Nov 2023

How next-gen sequencing is changing antibody drug discovery

New study outlines how next-generation sequencing (NGS) and machine-learning methods can revolutionize antibody discovery, particularly against SARS-CoV-2. The research demonstrates that NGS provides greater epitopic and paratopic diversity, enabling more effective identification and prioritization of therapeutic antibodies.

31 Oct 2023

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

In a recent study published in the British Journal of Psychiatry, researchers evaluated mortality in individuals with severe mental illness (SMI) following COVID-19.

31 Oct 2023

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Researchers investigated the prevalence rate of physical-type symptoms by the severity of acute COVID-19 beyond two years of diagnosis.

31 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5.

30 Oct 2023

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

People’s belief in COVID-19-related conspiracy theories (CTs) In Europe.

27 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

Researchers highlight the limitations and challenges of using AI models for diagnosing COVID-19 from chest X-rays shared via smartphones. The study introduces a new multi-task learning model to improve diagnostic accuracy, addressing issues like prediction instability and faulty focus areas in images.

25 Oct 2023

NF-κB activation during COVID-19 and its impact on patients with hypertension

Researchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

Community immunity: Steering the evolutionary course of SARS-CoV-2

Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.

24 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Masking up matters: High-quality studies confirm face masks significantly curb COVID-19 spread

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Influence of employment during COVID-19 on cognitive and motor functions among elders

How next-gen sequencing is changing antibody drug discovery

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

NF-κB activation during COVID-19 and its impact on patients with hypertension

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Community immunity: Steering the evolutionary course of SARS-CoV-2

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in